Non-Hodgkin's lymphomas clinical practice guidelines in oncology
Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval. © Journal of the National Comprehensive Cancer Network.
Additional Document Info
has global citation frequency